Delay Agnes, Moranne Olivier, Fafin Coraline, Mariat Christophe, Alamartine Eric, Delanaye Pierre, Maillard Nicolas
Service de Néphrologie, Dialyse, Transplantation Rénale, Hôpital Nord, CHU de Saint-Etienne, EA 3065, Université Jean MONNET, Saint-Etienne, France.
Service de Néphrologie, Dialyse, Aphérèse, Hôpital Caremeau, CHU de Nîmes, France.
Clin Kidney J. 2020 Dec 12;14(6):1665-1672. doi: 10.1093/ckj/sfaa203. eCollection 2021 Jun.
Glomerular filtration rate (GFR) decline ≥30% over 2 years can substitute for the conventional 'doubling of serum creatinine' to predict end-stage renal disease in patients with native kidneys. While chronic kidney disease trajectory is less predictable in transplanted patients, recent data have suggested that similar GFR decline might be an acceptable surrogate for long-term transplant outcome. We sought (i) to confirm the prognostic value of an early GFR decline in kidney transplant recipients and (ii) to determine whether using direct measurement of GFR with inulin improves the performance of this surrogate.
We retrospectively analysed all recipients transplanted between 1989 and 2000 in our centre, with inulin-measured and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)-estimated GFR at 1 and 5 years post-transplant, and evaluated the performance [time-dependent area under the receiver operating characteristic curve (ROC AUC) and subdistribution hazard ratio (sdHR) with competing risk model] of GFR change to predict graft failure and all-cause mortality.
Out of 417 kidney transplant recipients, 116 patients had lost their graft and 77 had died 16 years after transplantation. While being significantly associated with graft failure [sdHR = 2.37 (95% confidence interval 1.47-3.83)], CKD-EPI-GFR decline ≥30% failed to appropriately predict long-term graft survival (C-statistics of 0.63). Concordance between inulin-GFR and CKD-EPI-GFR to detect similar GFR change was only 53%. Inulin-GFR change was, however, not a better predictor (C-statistics of 0.59). Comparable results were observed for mortality.
Our data suggest that early GFR decline is a poor surrogate for long-term transplant outcome, even when change in GFR is directly measured by a reference method.
在2年内肾小球滤过率(GFR)下降≥30%可替代传统的“血清肌酐翻倍”来预测自体肾患者的终末期肾病。虽然移植患者的慢性肾脏病病程较难预测,但近期数据表明,类似的GFR下降可能是长期移植结局的可接受替代指标。我们旨在(i)证实早期GFR下降对肾移植受者的预后价值,以及(ii)确定使用菊粉直接测量GFR是否能改善该替代指标的性能。
我们回顾性分析了1989年至2000年间在本中心接受移植的所有受者,测量了移植后1年和5年时菊粉测定的GFR以及慢性肾脏病流行病学协作组(CKD-EPI)估算的GFR,并评估了GFR变化对预测移植失败和全因死亡率的性能[受试者操作特征曲线(ROC)的时间依赖性曲线下面积(AUC)以及竞争风险模型的亚分布风险比(sdHR)]。
在417例肾移植受者中,116例患者移植16年后移植肾失功,77例患者死亡。虽然CKD-EPI-GFR下降≥30%与移植失败显著相关[sdHR = 2.37(95%置信区间1.47 - 3.83)],但未能准确预测长期移植肾存活(C统计量为0.63)。菊粉-GFR与CKD-EPI-GFR检测相似GFR变化的一致性仅为53%。然而,菊粉-GFR变化也不是更好的预测指标(C统计量为0.59)。死亡率方面观察到类似结果。
我们的数据表明,即使通过参考方法直接测量GFR变化,早期GFR下降也不是长期移植结局的良好替代指标。